These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 14763473)

  • 21. Chronic dry eye in photorefractive keratectomy and laser in situ keratomileusis: Manifestations, incidence, and predictive factors.
    Bower KS; Sia RK; Ryan DS; Mines MJ; Dartt DA
    J Cataract Refract Surg; 2015 Dec; 41(12):2624-34. PubMed ID: 26796443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LASIK-associated dry eye and neurotrophic epitheliopathy: pathophysiology and strategies for prevention and treatment.
    Ambrósio R; Tervo T; Wilson SE
    J Refract Surg; 2008 Apr; 24(4):396-407. PubMed ID: 18500091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term Effects of LASIK on Corneal Innervation and Tear Neuropeptides and the Associations With Dry Eye.
    Chao C; Golebiowski B; Zhao X; Chen S; Zhou S; Stapleton F
    J Refract Surg; 2016 Aug; 32(8):518-24. PubMed ID: 27505312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing clinical and molecular outcomes of prophylactic thermal pulsation therapy on ocular surface health following refractive surgery.
    Shetty R; Khamar P; Nair AP; Pandian PR; Vaidya TA; Trivedi D; Sethu S; Roy S; Mahajan S; Shirodkar S
    Indian J Ophthalmol; 2023 Apr; 71(4):1508-1516. PubMed ID: 37026292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ocular surface management of photorefractive keratectomy and laser in situ keratomileusis.
    Albietz JM; McLennan SG; Lenton LM
    J Refract Surg; 2003; 19(6):636-44. PubMed ID: 14640428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dry eye disease after LASIK.
    Turu L; Alexandrescu C; Stana D; Tudosescu R
    J Med Life; 2012 Feb; 5(1):82-4. PubMed ID: 22574092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laser in situ keratomileusis-induced (presumed) neurotrophic epitheliopathy.
    Wilson SE
    Ophthalmology; 2001 Jun; 108(6):1082-7. PubMed ID: 11382633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is there a role for neurotrophin treatment of the ocular surface following laser in situ keratomileusis (LASIK)?
    Pepose JS; Johnson EM
    Am J Ophthalmol; 2005 Jun; 139(6):1090-4. PubMed ID: 15953442
    [No Abstract]   [Full Text] [Related]  

  • 29. Short-Term Impact of FS-LASIK and SMILE on Dry Eye Metrics and Corneal Nerve Morphology.
    Recchioni A; Sisó-Fuertes I; Hartwig A; Hamid A; Shortt AJ; Morris R; Vaswani S; Dermott J; Cerviño A; Wolffsohn JS; O'Donnell C
    Cornea; 2020 Jul; 39(7):851-857. PubMed ID: 32243424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of dry-eye disease severity after laser in situ keratomileusis and laser-assisted subepithelial keratectomy.
    Dooley I; D'Arcy F; O'Keefe M
    J Cataract Refract Surg; 2012 Jun; 38(6):1058-64. PubMed ID: 22624906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of corneal innervation in LASIK-induced neuropathic dry eye.
    Chao C; Golebiowski B; Stapleton F
    Ocul Surf; 2014 Jan; 12(1):32-45. PubMed ID: 24439045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes of Subjective Symptoms and Tear Film Biomarkers following Femto-LASIK.
    Tsai T; Alwees M; Rost A; Theile J; Dick HB; Joachim SC; Taneri S
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ocular surface treatment before laser in situ keratomileusis in patients with severe dry eye.
    Toda I; Asano-Kato N; Hori-Komai Y; Tsubota K
    J Refract Surg; 2004; 20(3):270-5. PubMed ID: 15188906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of punctal occlusion in management of dry eyes after laser in situ keratomileusis for myopia.
    Alfawaz AM; Algehedan S; Jastaneiah SS; Al-Mansouri S; Mousa A; Al-Assiri A
    Curr Eye Res; 2014 Mar; 39(3):257-62. PubMed ID: 24147767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thin-Flap Laser In Situ Keratomileusis-Associated Dry Eye: A Comparative Study Between Femtosecond Laser and Mechanical Microkeratome-Assisted Laser In Situ Keratomileusis.
    Abdel-Radi M; Abdelmotaal H; Anwar M
    Eye Contact Lens; 2022 Jan; 48(1):20-26. PubMed ID: 34644283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early changes in ocular surface and tear inflammatory mediators after small-incision lenticule extraction and femtosecond laser-assisted laser in situ keratomileusis.
    Gao S; Li S; Liu L; Wang Y; Ding H; Li L; Zhong X
    PLoS One; 2014; 9(9):e107370. PubMed ID: 25211490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid tear deficiency in persistent dry eye after laser in situ keratomileusis and treatment results of new eye-warming device.
    Di Pascuale MA; Liu TS; Trattler W; Tseng SC
    J Cataract Refract Surg; 2005 Sep; 31(9):1741-9. PubMed ID: 16246778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A new approach for better comprehension of diseases of the ocular surface].
    Baudouin C
    J Fr Ophtalmol; 2007 Mar; 30(3):239-46. PubMed ID: 17417148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ocular surface changes in laser in situ keratomileusis-induced neurotrophic epitheliopathy.
    Savini G; Barboni P; Zanini M; Tseng SC
    J Refract Surg; 2004; 20(6):803-9. PubMed ID: 15586763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tear dysfunction from lacrimal gland to LASIK.
    Foulks GN
    Ocul Surf; 2010 Jul; 8(3):99. PubMed ID: 20712967
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.